ADA17_HUMAN - dbPTM
ADA17_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ADA17_HUMAN
UniProt AC P78536
Protein Name Disintegrin and metalloproteinase domain-containing protein 17
Gene Name ADAM17
Organism Homo sapiens (Human).
Sequence Length 824
Subcellular Localization Membrane
Single-pass type I membrane protein.
Protein Description Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein. Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT). Plays a role in the proteolytic processing of ACE2..
Protein Sequence MRQSLLFLTSVVPFVLAPRPPDDPGFGPHQRLEKLDSLLSDYDILSLSNIQQHSVRKRDLQTSTHVETLLTFSALKRHFKLYLTSSTERFSQNFKVVVVDGKNESEYTVKWQDFFTGHVVGEPDSRVLAHIRDDDVIIRINTDGAEYNIEPLWRFVNDTKDKRMLVYKSEDIKNVSRLQSPKVCGYLKVDNEELLPKGLVDREPPEELVHRVKRRADPDPMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTSWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYVGSPRANSHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSNCSKQSIYKTIESKAQECFQERSNKVCGNSRVDEGEECDPGIMYLNNDTCCNSDCTLKEGVQCSDRNSPCCKNCQFETAQKKCQEAINATCKGVSYCTGNSSECPPPGNAEDDTVCLDLGKCKDGKCIPFCEREQQLESCACNETDNSCKVCCRDLSGRCVPYVDAEQKNLFLRKGKPCTVGFCDMNGKCEKRVQDVIERFWDFIDQLSINTFGKFLADNIVGSVLVFSLIFWIPFSILVHCVDKKLDKQYESLSLFHPSNVEMLSSMDSASVRIIKPFPAPQTPGRLQPAPVIPSAPAAPKLDHQRMDTIQEDPSTDSHMDEDGFEKDPFPNSSTAAKSFEDLTDHPVTRSEKAASFKLQRQNRVDSKETEC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MRQSLLFLTSV
----CCCHHHHHHCC
19.3727732954
9PhosphorylationRQSLLFLTSVVPFVL
CCHHHHHHCCCCEEE
16.4927732954
10PhosphorylationQSLLFLTSVVPFVLA
CHHHHHHCCCCEEEC
24.2227732954
82PhosphorylationLKRHFKLYLTSSTER
HHHHHEEEECCCCHH
14.44-
84PhosphorylationRHFKLYLTSSTERFS
HHHEEEECCCCHHHC
13.6927362937
87PhosphorylationKLYLTSSTERFSQNF
EEEECCCCHHHCCCE
30.8327362937
102UbiquitinationKVVVVDGKNESEYTV
EEEEECCCCCCEEEE
53.75-
103N-linked_GlycosylationVVVVDGKNESEYTVK
EEEECCCCCCEEEEE
64.65UniProtKB CARBOHYD
157N-linked_GlycosylationEPLWRFVNDTKDKRM
HHHHHHHCCCCCCEE
48.82UniProtKB CARBOHYD
168 (in isoform 2)Ubiquitination-39.6321906983
168 (in isoform 1)Ubiquitination-39.6321890473
168UbiquitinationDKRMLVYKSEDIKNV
CCEEEEEECHHHCCH
39.6321906983
174N-linked_GlycosylationYKSEDIKNVSRLQSP
EECHHHCCHHHCCCC
37.01UniProtKB CARBOHYD
180PhosphorylationKNVSRLQSPKVCGYL
CCHHHCCCCCCCCEE
31.1426091039
182UbiquitinationVSRLQSPKVCGYLKV
HHHCCCCCCCCEEEE
56.24-
186PhosphorylationQSPKVCGYLKVDNEE
CCCCCCCEEEECCHH
9.7523403867
197UbiquitinationDNEELLPKGLVDREP
CCHHHCCCCCCCCCC
65.92-
262PhosphorylationIDRVDDIYRNTSWDN
HHHHHHHHHCCCCCC
12.5729978859
264N-linked_GlycosylationRVDDIYRNTSWDNAG
HHHHHHHCCCCCCCC
22.84UniProtKB CARBOHYD
265PhosphorylationVDDIYRNTSWDNAGF
HHHHHHCCCCCCCCC
23.3829978859
266PhosphorylationDDIYRNTSWDNAGFK
HHHHHCCCCCCCCCC
35.6629978859
273 (in isoform 2)Ubiquitination-50.75-
302UbiquitinationEKHYNMAKSYPNEEK
CCCCCCCCCCCCCCC
39.4921906983
302 (in isoform 2)Ubiquitination-39.4921906983
302 (in isoform 1)Ubiquitination-39.4921890473
309UbiquitinationKSYPNEEKDAWDVKM
CCCCCCCCCHHHHHH
46.71-
360PhosphorylationVGSPRANSHGGVCPK
ECCCCCCCCCCCCCC
23.6430631047
376UbiquitinationYYSPVGKKNIYLNSG
CCCCCCCCEEEECCC
42.52-
379PhosphorylationPVGKKNIYLNSGLTS
CCCCCEEEECCCCCC
14.8222817900
382PhosphorylationKKNIYLNSGLTSTKN
CCEEEECCCCCCCCC
32.3622817900
388UbiquitinationNSGLTSTKNYGKTIL
CCCCCCCCCCCCEEE
48.19-
392UbiquitinationTSTKNYGKTILTKEA
CCCCCCCCEEEECCC
23.25-
433PhosphorylationNEDQGGKYVMYPIAV
CCCCCCCEEEEEEEE
8.17-
436PhosphorylationQGGKYVMYPIAVSGD
CCCCEEEEEEEEECC
4.97-
452N-linked_GlycosylationENNKMFSNCSKQSIY
CCCCCCCCCCHHHHH
23.86UniProtKB CARBOHYD
460UbiquitinationCSKQSIYKTIESKAQ
CCHHHHHHHHHHHHH
41.16-
465UbiquitinationIYKTIESKAQECFQE
HHHHHHHHHHHHHHH
41.10-
498N-linked_GlycosylationPGIMYLNNDTCCNSD
CCCEEECCCCCCCCC
43.29UniProtKB CARBOHYD
539N-linked_GlycosylationKKCQEAINATCKGVS
HHHHHHHHHHHCCCH
35.92UniProtKB CARBOHYD
551N-linked_GlycosylationGVSYCTGNSSECPPP
CCHHCCCCCCCCCCC
24.98UniProtKB CARBOHYD
594N-linked_GlycosylationQLESCACNETDNSCK
HHHHHHCCCCCCCCE
36.3617660510
608PhosphorylationKVCCRDLSGRCVPYV
EEEEECCCCCEEECC
28.6022210691
614PhosphorylationLSGRCVPYVDAEQKN
CCCCEEECCCHHHHC
7.2022210691
620UbiquitinationPYVDAEQKNLFLRKG
ECCCHHHHCEEECCC
47.31-
631PhosphorylationLRKGKPCTVGFCDMN
ECCCCCCEEEEECCC
31.9929759185
702PhosphorylationDKKLDKQYESLSLFH
CHHHHHHHHHCCCCC
17.1527642862
706PhosphorylationDKQYESLSLFHPSNV
HHHHHHCCCCCHHHH
37.96-
711PhosphorylationSLSLFHPSNVEMLSS
HCCCCCHHHHHHHHC
44.9622210691
717PhosphorylationPSNVEMLSSMDSASV
HHHHHHHHCCCCCEE
23.4722210691
718PhosphorylationSNVEMLSSMDSASVR
HHHHHHHCCCCCEEE
23.7328348404
721PhosphorylationEMLSSMDSASVRIIK
HHHHCCCCCEEEEEC
17.5028857561
723PhosphorylationLSSMDSASVRIIKPF
HHCCCCCEEEEECCC
18.8428857561
728 (in isoform 1)Ubiquitination-37.9321890473
728UbiquitinationSASVRIIKPFPAPQT
CCEEEEECCCCCCCC
37.9321890473
735PhosphorylationKPFPAPQTPGRLQPA
CCCCCCCCCCCCCCC
27.0130266825
747PhosphorylationQPAPVIPSAPAAPKL
CCCCCCCCCCCCCCC
35.4423312004
753UbiquitinationPSAPAAPKLDHQRMD
CCCCCCCCCCCCCCC
62.92-
761PhosphorylationLDHQRMDTIQEDPST
CCCCCCCCCCCCCCC
18.4130266825
767PhosphorylationDTIQEDPSTDSHMDE
CCCCCCCCCCCCCCC
58.1130266825
768PhosphorylationTIQEDPSTDSHMDED
CCCCCCCCCCCCCCC
47.0830266825
770PhosphorylationQEDPSTDSHMDEDGF
CCCCCCCCCCCCCCC
22.3130266825
779UbiquitinationMDEDGFEKDPFPNSS
CCCCCCCCCCCCCCH
69.3221906983
779 (in isoform 1)Ubiquitination-69.3221890473
785PhosphorylationEKDPFPNSSTAAKSF
CCCCCCCCHHHHHHH
29.3330266825
786PhosphorylationKDPFPNSSTAAKSFE
CCCCCCCHHHHHHHH
28.8030266825
787PhosphorylationDPFPNSSTAAKSFED
CCCCCCHHHHHHHHH
30.3830266825
790UbiquitinationPNSSTAAKSFEDLTD
CCCHHHHHHHHHHCC
53.892190698
790 (in isoform 1)Ubiquitination-53.8921890473
791PhosphorylationNSSTAAKSFEDLTDH
CCHHHHHHHHHHCCC
29.1929255136
791DephosphorylationNSSTAAKSFEDLTDH
CCHHHHHHHHHHCCC
29.1912621058
796PhosphorylationAKSFEDLTDHPVTRS
HHHHHHHCCCCCCCC
44.5823927012
801PhosphorylationDLTDHPVTRSEKAAS
HHCCCCCCCCHHHHH
32.6923403867
805UbiquitinationHPVTRSEKAASFKLQ
CCCCCCHHHHHHHHH
50.96-
808PhosphorylationTRSEKAASFKLQRQN
CCCHHHHHHHHHHHC
27.9827422710
810UbiquitinationSEKAASFKLQRQNRV
CHHHHHHHHHHHCCC
41.01-
819PhosphorylationQRQNRVDSKETEC--
HHHCCCCCCCCCC--
29.5423898821
822PhosphorylationNRVDSKETEC-----
CCCCCCCCCC-----
46.5228102081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
735TPhosphorylationKinasePRKCAP17252
GPS
735TPhosphorylationKinasePRKCDQ05655
GPS
735TPhosphorylationKinasePRKCEQ02156
GPS
735TPhosphorylationKinaseMAPK1P28482
GPS
735TPhosphorylationKinaseMAPK3P27361
GPS
735TPhosphorylationKinaseP38AQ16539
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
735TPhosphorylation

12058067
791SPhosphorylation

17081983
819SPhosphorylation

12621058

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ADA17_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DLG1_HUMANDLG1physical
12668732
MK01_HUMANMAPK1physical
12058067
MD2L1_HUMANMAD2L1physical
10527948
MD2L1_HUMANMAD2L1physical
11741929
TNR1A_HUMANTNFRSF1Aphysical
17010968
TNR1B_HUMANTNFRSF1Bphysical
17010968
DLG1_HUMANDLG1physical
18930083
SDK2_HUMANSDK2physical
28514442
LRRC3_HUMANLRRC3physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
614328Inflammatory skin and bowel disease, neonatal, 1 (NISBD1)
Kegg Drug
D08859 Apratastat (USAN/INN)
D09320 Aderbasib (USAN/INN)
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ADA17_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-791, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-379; SER-382 ANDSER-791, AND MASS SPECTROMETRY.
"Direct activation of TACE-mediated ectodomain shedding by p38 MAPkinase regulates EGF receptor-dependent cell proliferation.";
Xu P., Derynck R.;
Mol. Cell 37:551-566(2010).
Cited for: PHOSPHORYLATION AT THR-735, AND INTERACTION WITH MAPK14.
"Extracellular signal-regulated kinase phosphorylates tumor necrosisfactor alpha-converting enzyme at threonine 735: a potential role inregulated shedding.";
Diaz-Rodriguez E., Montero J.C., Esparis-Ogando A., Yuste L.,Pandiella A.;
Mol. Biol. Cell 13:2031-2044(2002).
Cited for: PHOSPHORYLATION AT THR-735.

TOP